These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8525667)

  • 1. [New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
    Schächinger V; Zeiher AM
    Z Kardiol; 1995 Sep; 84(9):651-67. PubMed ID: 8525667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current approach in antithrombotic treatment during coronary interventions: specific thrombocyte aggregation inhibitors and direct thrombin antagonists in high-risk patients].
    Meyer BJ
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1961-9. PubMed ID: 8984604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does platelet glycoprotein IIb/IIIa receptor antibody improve in-hospital outcome of coronary stenting in high-risk thrombus containing lesions?
    Piamsomboon C; Wong PM; Mathur A; Singh D; Liu MW; Baxley WA; Iyer SS; Dean LS; Roubin GS
    Catheter Cardiovasc Interv; 1999 Apr; 46(4):415-20. PubMed ID: 10216005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet and anticoagulant therapy in patients undergoing percutaneous transluminal coronary angioplasty.
    Barry WL; Sarembock IJ
    Cardiol Clin; 1994 Aug; 12(3):517-35. PubMed ID: 7805084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal antithrombotic treatment for percutaneous coronary intervention.
    Kadakia RA; Ferguson JJ
    Minerva Cardioangiol; 2005 Feb; 53(1):15-42. PubMed ID: 15788977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
    Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
    Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty.
    Unterberg C; Sandrock D; Nebendahl K; Buchwald AB
    J Am Coll Cardiol; 1995 Dec; 26(7):1747-54. PubMed ID: 7594113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition.
    Ferguson JJ; Waly HM; Wilson JM
    Eur Heart J; 1998 Apr; 19 Suppl D():D3-9. PubMed ID: 9597517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wall passivation for unstable angina.
    Lettino M; Dailey-Sterling F; Badimon L; Chesebro JH; Badimon JJ
    Semin Interv Cardiol; 1996 Mar; 1(1):60-6. PubMed ID: 9552495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of acute coronary syndrome. Aspirin, heparin, low-molecular-weight heparin, hirudin and GP-IIb/IIIa blockers].
    Gaede A; Terres W
    Herz; 1999 Aug; 24(5):353-62. PubMed ID: 10505285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to the prevention of thrombotic restenosis after angioplasty or thrombolysis.
    Golino P; Chiariello M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S41-7. PubMed ID: 1717772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New anticoagulant strategies.
    Weitz J; Hirsh J
    J Lab Clin Med; 1993 Oct; 122(4):364-73. PubMed ID: 8228551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of intracoronary thrombosis complicating percutaneous transluminal coronary angioplasty.
    Boston DR; Malouf A; Barry WH
    Clin Cardiol; 1996 Jul; 19(7):536-42. PubMed ID: 8818433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition.
    Ferguson JJ; Waly HM; Wilson JM
    Am Heart J; 1998 Apr; 135(4):S35-42. PubMed ID: 9539494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins.
    Chesebro JH; Webster MW; Zoldhelyi P; Roche PC; Badimon L; Badimon JJ
    Circulation; 1992 Dec; 86(6 Suppl):III100-10. PubMed ID: 1424043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis].
    Weber MA; Lorenz RL; Schramm W; Theisen K
    Z Kardiol; 1986; 75 Suppl 5():107-11. PubMed ID: 2950673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelets and thrombin: implications for treatment of coronary artery thrombosis.
    Runge MS; Bode C
    Z Kardiol; 1993; 82 Suppl 2():83-8. PubMed ID: 8328214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.